TREATMENT OF DEMYELINATING DISORDERS WITH SOLUBLE LYMPHOTOXIN-BETA-RECEPTOR

• 收藏
• 分享

专利权人:

BIOGEN IDEC MA INC.

发明人:

BROWNING, JEFFREY,TING, JENNY P-Y

申请号：

NZ57642407

公开号：

NZ576424A

申请日:

2007.10.18

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

Disclosed is the use of a soluble Lymphotoxin-beta-Receptor (LTbetaR) and a pharmaceutically acceptable carrier in the manufacture of a medicament for promoting remyelination in a human subject having a demyelinating disorder, wherein said medicament is formulated for administration to the subject and in which remyelination in the subject is to be monitored

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/